Skip to content
OpenCapital
Get started

NeoGenomics NEO Reportable Segment — Investment Income, Interest

Similar metrics at other companies

Indivior Pharmaceuticals, Inc. logo
INDVReportable Segment — Investment Income, Interest
$3M-25.0%
Zevra Therapeutics, Inc. logo
ZVRAReportable Segment — Investment Income, Interest
$2.18M+204%
Upwork Inc. logo
UPWKReportable Segment — Investment income, interest
$5.85M-17.6%
Century Aluminum logo
CENXReportable Segment — Interest Income
$3.1M+72.2%
SiTime Corporation logo
SITMReportable Segment — Investment Income, Interest
$7.31M+70.2%
Arcutis Biotherapeutics, Inc. logo
ARQTReportable Segment — Interest Income
$2.28M-10.3%

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B+86.5%
Enterprise value$1.6B+159%
P/S2.3×+0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%—

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's reportable segment — investment income, interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's reportable segment — investment income, interest?
NeoGenomics (NEO) reported reportable segment — investment income, interest of $1.27M in Q1 2026.
How has NeoGenomics's reportable segment — investment income, interest changed year-over-year?
NeoGenomics's reportable segment — investment income, interest decreased by 65.8% year-over-year, from $3.72M to $1.27M.
What is the long-term trend for NeoGenomics's reportable segment — investment income, interest?
Over 3 years (2022 to 2025), NeoGenomics's reportable segment — investment income, interest has grown at a 14.3% compound annual growth rate (CAGR), from $6.08M to $9.07M.
What does reportable segment — investment income, interest mean?
Income earned from cash balances, short-term investments, or other financial instruments held by the segment. This reflects the segment's ability to generate returns on its excess liquidity or cash reserves.